The economic and human costs of osteoporotic fracture
- PMID: 7709931
- DOI: 10.1016/s0002-9343(05)80037-3
The economic and human costs of osteoporotic fracture
Similar articles
-
The societal burden of osteoporosis in Sweden.Bone. 2007 Jun;40(6):1602-9. doi: 10.1016/j.bone.2007.02.027. Epub 2007 Mar 7. Bone. 2007. PMID: 17433804
-
Cost-equivalence of different osteoporotic fractures.Osteoporos Int. 2003 Jun;14(5):383-8. doi: 10.1007/s00198-003-1385-4. Epub 2003 Apr 1. Osteoporos Int. 2003. PMID: 12730750
-
Epidemiology of osteoporotic fractures.Osteoporos Int. 2005 Mar;16 Suppl 2:S3-7. doi: 10.1007/s00198-004-1702-6. Epub 2004 Sep 8. Osteoporos Int. 2005. PMID: 15365697 Review.
-
Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture I.Curr Med Res Opin. 2008 Jun;24(6):1781-8. doi: 10.1185/03007990802115796. Epub 2008 May 16. Curr Med Res Opin. 2008. PMID: 18489813 Review.
-
[Absolute risk for fracture and WHO guideline. Economic analysis of pharmacotherapy for osteoporosis].Clin Calcium. 2007 Jul;17(7):1029-34. Clin Calcium. 2007. PMID: 17607069 Review. Japanese.
Cited by
-
Efficacy and cost-effectiveness of nutritional intervention in elderly after hip fracture: design of a randomized controlled trial.BMC Public Health. 2010 Apr 27;10:212. doi: 10.1186/1471-2458-10-212. BMC Public Health. 2010. PMID: 20423469 Free PMC article. Clinical Trial.
-
Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development.Drugs Aging. 2007;24(5):361-79. doi: 10.2165/00002512-200724050-00002. Drugs Aging. 2007. PMID: 17503894 Review.
-
The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation.AAPS PharmSciTech. 2011 Mar;12(1):304-11. doi: 10.1208/s12249-011-9585-2. Epub 2011 Jan 27. AAPS PharmSciTech. 2011. PMID: 21271316 Free PMC article.
-
Prevalence and Risk Factors for Osteopathy in Chronic Pancreatitis.Dig Dis Sci. 2021 Nov;66(11):4008-4016. doi: 10.1007/s10620-020-06732-2. Epub 2021 Jan 12. Dig Dis Sci. 2021. PMID: 33433813
-
Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women.Ann Rheum Dis. 2003 Oct;62(10):969-75. doi: 10.1136/ard.62.10.969. Ann Rheum Dis. 2003. PMID: 12972476 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical